2:I[6146,[],""]
3:I[4411,[],""]
4:"$Sreact.suspense"
5:I[7256,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"KeyboardNavigation"]
6:I[5407,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"SlideNavigation"]
0:["DkpgZd6XOJjDaY981EGFp",[[["",{"children":["pages",{"children":["5",{"children":["__PAGE__",{}]}]}]},"$undefined","$undefined",true],["",{"children":["pages",{"children":["5",{"children":["__PAGE__",{},[["$L1",["$","div",null,{"className":"relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700 text-white","children":["$","div",null,{"className":"flex flex-col w-full h-full","children":[["$","div",null,{"className":"flex-none bg-slate-800/90 p-6 flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":48,"height":48,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-users text-blue-400","children":[["$","path","1yyitq",{"d":"M16 21v-2a4 4 0 0 0-4-4H6a4 4 0 0 0-4 4v2"}],["$","circle","nufk8",{"cx":"9","cy":"7","r":"4"}],["$","path","kshegd",{"d":"M22 21v-2a4 4 0 0 0-3-3.87"}],["$","path","1da9ce",{"d":"M16 3.13a4 4 0 0 1 0 7.75"}],"$undefined"]}],["$","h1",null,{"className":"text-6xl font-bold text-white","children":"Competitive Landscape Analysis"}]]}],["$","div",null,{"className":"flex-1 min-h-0 flex flex-col p-8 gap-6","children":[["$","div",null,{"className":"flex-none","children":[["$","h2",null,{"className":"text-4xl font-bold text-white mb-2","children":"Direct Competition: Advanced cSCC Treatment Market"}],["$","p",null,{"className":"text-2xl text-gray-300","children":"Unloxcyt enters a market dominated by established PD-1 inhibitors with proven track records"}]]}],["$","div",null,{"className":"flex-1 min-h-0 overflow-hidden","children":["$","div",null,{"className":"bg-slate-800/90 rounded-lg overflow-hidden h-full","children":["$","table",null,{"className":"w-full h-full","children":[["$","thead",null,{"children":["$","tr",null,{"className":"bg-slate-700 border-b-2 border-blue-400","children":[["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Product"}],["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Company"}],["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Mechanism"}],["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Approval Year"}],["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Metastatic cSCC ORR"}],["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Key Advantage"}],["$","th",null,{"className":"text-2xl font-bold text-white p-4 text-left","children":"Weakness"}]]}]}],["$","tbody",null,{"children":[["$","tr",null,{"className":"bg-slate-800 border-l-4 border-purple-400","children":[["$","td",null,{"className":"text-2xl p-4 font-bold text-purple-400","children":"Unloxcyt"}],["$","td",null,{"className":"text-2xl p-4","children":"Sun Pharma"}],["$","td",null,{"className":"text-2xl p-4","children":"PD-L1 + ADCC"}],["$","td",null,{"className":"text-2xl p-4","children":"2024"}],["$","td",null,{"className":"text-2xl p-4 font-bold text-green-400","children":"47%"}],["$","td",null,{"className":"text-2xl p-4 text-green-300","children":"First PD-L1, ADCC activity"}],["$","td",null,{"className":"text-2xl p-4 text-orange-300","children":"Late market entry"}]]}],["$","tr",null,{"className":"bg-slate-700/50","children":[["$","td",null,{"className":"text-2xl p-4 font-bold","children":"Keytruda"}],["$","td",null,{"className":"text-2xl p-4","children":"Merck"}],["$","td",null,{"className":"text-2xl p-4","children":"PD-1"}],["$","td",null,{"className":"text-2xl p-4","children":"2020"}],["$","td",null,{"className":"text-2xl p-4","children":"35%"}],["$","td",null,{"className":"text-2xl p-4 text-green-300","children":"Market leader, brand trust"}],["$","td",null,{"className":"text-2xl p-4 text-orange-300","children":"Lower ORR vs Unloxcyt"}]]}],["$","tr",null,{"className":"bg-slate-800","children":[["$","td",null,{"className":"text-2xl p-4 font-bold","children":"Libtayo"}],["$","td",null,{"className":"text-2xl p-4","children":"Regeneron"}],["$","td",null,{"className":"text-2xl p-4","children":"PD-1"}],["$","td",null,{"className":"text-2xl p-4","children":"2018"}],["$","td",null,{"className":"text-2xl p-4","children":"Variable"}],["$","td",null,{"className":"text-2xl p-4 text-green-300","children":"First-mover, durability data"}],["$","td",null,{"className":"text-2xl p-4 text-orange-300","children":"Limited differentiation"}]]}],["$","tr",null,{"className":"bg-slate-700/50","children":[["$","td",null,{"className":"text-2xl p-4 font-bold","children":"Opdivo"}],["$","td",null,{"className":"text-2xl p-4","children":"Bristol-Myers"}],["$","td",null,{"className":"text-2xl p-4","children":"PD-1"}],["$","td",null,{"className":"text-2xl p-4","children":"2014 (other)"}],["$","td",null,{"className":"text-2xl p-4","children":"N/A for cSCC"}],["$","td",null,{"className":"text-2xl p-4 text-green-300","children":"Broad oncology portfolio"}],["$","td",null,{"className":"text-2xl p-4 text-orange-300","children":"Not cSCC-specific"}]]}]]}]]}]}]}],["$","div",null,{"className":"flex-none bg-slate-800/90 p-6 rounded-lg border border-slate-700","children":[["$","h3",null,{"className":"text-3xl font-bold text-white mb-4","children":"Competitive Positioning Insights"}],["$","div",null,{"className":"grid grid-cols-1 gap-4","children":[["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-xl","children":[["$","strong",null,{"children":"Market Concentration:"}]," Top 3 brands captured 91% of global PD-1/PD-L1 sales in 2021"]}]]}],["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-xl","children":[["$","strong",null,{"children":"Differentiation Opportunity:"}]," Unloxcyt's PD-L1 mechanism and ADCC provide legitimate clinical differentiation"]}]]}],["$","div",null,{"className":"flex items-start gap-3","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":20,"height":20,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-circle-check-big text-blue-400 mt-1","children":[["$","path","yps3ct",{"d":"M21.801 10A10 10 0 1 1 17 3.335"}],["$","path","1pflzl",{"d":"m9 11 3 3L22 4"}],"$undefined"]}],["$","p",null,{"className":"text-xl","children":[["$","strong",null,{"children":"Market Size Justification:"}]," $1B+ U.S. cSCC market supports multiple successful competitors"]}]]}]]}]]}]]}],["$","div",null,{"className":"flex-none p-4 text-right","children":["$","p",null,{"className":"text-xl text-gray-400","children":"5"}]}]]}]}],null],null],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children","5","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/8d323862949ffad9.css","precedence":"next","crossOrigin":"$undefined"}]],["$","html",null,{"lang":"en","className":"dark","children":["$","body",null,{"className":"__className_f367f3 h-1080px w-1920px","children":[["$","$4",null,{"fallback":null,"children":[["$","$L5",null,{}],["$","$L6",null,{}]]}],["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":"404"}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],"notFoundStyles":[]}]]}]}]],null],null],["$L7",null]]]]
7:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Unloxcyt Market Survey - Interactive Presentation"}],["$","meta","3",{"name":"description","content":"Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC"}],["$","meta","4",{"name":"next-size-adjust"}]]
1:null
